Unfortunately, unlike non-small cell lung cancers including lung SCC, which exhibit a good PD-1 ICI response [4], only 10% of PD-1 ICI-treated HNSCC demonstrated a durable long-term response [5]. Here, PDCD1 is linked to non-small cell lung carcinoma.